0314.HK · SIPAI HEALTH
Hong Kong · RS rating 17 · As of 2026-10-14
| Price | 1.35 HKD |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 14 / 48 / 14 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 16 / 6 / 2 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +58.3% |
| Market cap (USD) | $130.3M |